Professor of Medicine, University of Texas Medical Branch at Galveston
Endocrinology
Dr. Owen B. Holland, MD
|
|
Give Review
Owen Holland practices Endocrinology. He received awards:"Top Doctors:SE Texas" and "CMS Meaningful Use Stage 1 Certification". Owen B. Holland is a published doctor and has 83 publications published. The lastest was: 'Circadian rhythms of serum renin activity and serum corticosterone, prolactin, and aldosterone concentrations in the male rat on normal and low-sodium diets.' Owen Holland accepts Medicare.
Publications
- Exploration and high adventure: the legacy of Grey Walter.
- Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human Adrenal NCI-H295 cells.
- Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin.
- Angiotensin increases aldosterone synthase mRNA levels in human NCI-H295 cells.
- Aldosterone synthase gene regulation by angiotensin.
- Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
- Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
- Attenuation of diuretic-induced Hypokalemia by amiloride, a potassium-sparing agent.
- Diuretic-induced ventricular ectopic activity.
- Urinary excretion of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes.
- Effect of guanabenz and hydrochlorothiazide on blood pressure and plasma renin activity.
- Rapid chromatographic purification of urinary steroid glucuronates for determination of aldosterone secretion rate.
- Diuretic-induced hypokalaemia and ventricular arrhythmias.
- Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism.
- Further evaluation of saline infusion for the diagnosis of primary aldosteronism.
- Mineralocorticoids and hypertension.
- Synergistic effect of captopril With hydrochlorothiazide for the treatment of low-renin hypertensive black patients.
- Aldosterone suppression With dopamine infusion in low-renin hypertension.
- Plasma substance P levels in normotensive and hypertensive subjects.
- Renin classification for diuretic and beta-blocker treatment of black hypertensive patients.
- Characteristics of Adrenal-regeneration and aldosterone hypertension.
- Acute and chronic influence of diazoxide on Adrenal-regeneration hypertension.
- Benign and malignant hypertension after Adrenal enucleation in the rat. Relationship to salt intake, response to hydrochlorothiazide, and similarity to essential hyper...
- Evolution of Adrenal regeneration hypertension in rats with actively regenerating or fully regenerated glands.
- Prevention and reversal of Adrenal-regeneration hypertension with hydrochlorothiazide.
- Hormonally maintained high blood pressure following Adrenalectomy in rats with Adrenal-regeneration hypertension and its possible significance in the etiology of that ...
- Influence of hydrochlorothiazide on fluid consumption, blood pressure, and organ changes in rats subjected to hypersalimentation or augmented hypersalimentation.
- Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
- Determination of aldosterone secretion rate utilizing mixed mode and high performance liquid chromatography.
- Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients.
- Regulation of lipolysis in severely burned children.
- High-performance liquid chromatography in the radioimmunoassay of urinary tetrahydroaldosterone.
- Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects.
- Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart.
- Systemic and regional hemodynamic effects of calcitonin gene-related peptide.
- Haemodynamic response to magnesium administration in mineralocorticoid-salt and two-kidney, one clip renovascular hypertension.
- Simplified method for the determination of plasma 18-hydroxycorticosterone.
- Role of 18-hydroxylated cortisols in hypertension.
- Metabolic changes With antihypertensive therapy of the salt-sensitive patient.
- Dietary Calcium modulates spinal cord content of calcitonin gene-related peptide in the rat.
- The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
- Ventricular ectopic activity With diuretic therapy.
- Urinary 18-hydroxycortisol and its relationship to the excretion of other Adrenal steroids.
- Systemic and regional hemodynamic effects of dietary Calcium supplementation in mineralocorticoid hypertension.
- Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive Diabetic patient. Enalapril for hypertensive Diabetics.
- Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide.
- Effect of short- and long-term beta-adrenergic blockade on lipolysis during fasting in humans.
- 18-oxocortisol: effect of dexamethasone, ACTH and sodium restriction.
- Importance of blood glucose concentration in regulating lipolysis during fasting in humans.
- Effects of Calcium channel blockade on Calcium homeostasis in mild to moderate essential hypertension.
- Humoral factors determining the blood pressure response to converting enzyme inhibition and Calcium channel blockade.
- Combination of converting enzyme inhibitor With diuretic for the treatment of hypertension.
- Effect of dietary Calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension.
- Hypoaldosteronism--Disease or normal response?
- Decreased spinal cord content of calcitonin gene-related peptide in the spontaneously hypertensive rat.
- Drug-induced hypokalaemia. A cause for concern.
- Systemic and regional hemodynamic effects of 1,25-dihydroxyvitamin D3 administration.
- Propranolol in the treatment of hypertension.
- Circadian rhythms of serum renin activity and serum corticosterone, prolactin, and aldosterone concentrations in the male rat on normal and low-sodium diets.
- The intravenous furosemide test: a simple way to evaluate renin responsiveness.
- Evidence against prolactin stimulation of aldosterone in normal human subjects and patients With primary aldosteronism, including a patient With primary aldosteronism ...
- Effect of intraventricular infusions of artificial cerebrospinal fluid on serum renin activity, aldosterone, corticosterone, and prolactin (39869).
- Radioiodinated derivatives for steroid radioimmunoassay. Application to the radioimmunoassay of cortisol.
- Single-voided urine metanephrine assays in screening for pheochromocytoma.
- Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
- Role of renin classification for diuretic treatment of black hypertensive patients.
- Hypertension With mineralocorticoid administration to the Long-Evans rat.
- 19-nor-deoxycorticosterone: a potent mineralcocorticoid isolated from the urine of rats with regenerating Adrenals.
- Early cardiovascular adaptation to simulated zero gravity.
- Withdrawal syndrome following cessation of guanabenz therapy.
- Antihypertensive comparison of furosemide With hydrochlorothiazide for black patients.
- Plasma aldosterone response to ACTH in primary aldosteronism and in patients With low renin hypertension.
- On the mineralocorticoid and hypertensogenic properties of 16beta-hydroxy-dehydroepiandrosterone.
- Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man.
- Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
- Specific binding of [3H]-16 beta-hydroxydehydroepiandrosterone by rat kidney.
- Plasma dehydroepiandrosterone sulfate concentration in essential hypertension.
- Interaction of 16beta-hydroxydehydroepiandrosterone With renal mineralocorticoid receptors.
- Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids.
- Effect of deoxycorticosterone acetate and 16beta-hydroxy-dehydroepiandrosterone on blood pressure and plasma renin activity of rats.
- Prolactin in hypertension.
- Mineralocorticoid radioreceptor assay: application to Adrenal-regeneration hypertension.
Schools
University Of Texas Medical Branch At Galveston
John Sealy Hospital
Parkland Memorial Hospital
University Tex Health Science Center
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Advantage HMO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- GEHA
- Health Alliance
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Old Surety Life Insurance CompanyMedicare MCR
- Principal Life
- Pyramid Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Top Doctors:SE Texas
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Texas Medical Branch Hospitals -
University of Texas Medical Branch
Drug Facts
| NPI NUMBER | 1982622148 | |
| NPPES Provider LastName | HOLLAND | |
| NPPES Provider FirstName | OWEN | |
| NPPES Provider ZIPCode | 775555302 | |
| NPPES Provider State | TX | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 2952.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982622148 |
| Last Name Of The Provider | HOLLAND |
| First Name Of The Provider | OWEN |
| View All |
Similar Doctors
|
|
Dr. Sorin G. Beca, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan R. Brasier, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ligia M. Belalcazar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marita D. Fisher, MD |